Bioceres Crop Solutions (BIOX) Cash from Financing Activities (2017 - 2025)

Bioceres Crop Solutions has reported Cash from Financing Activities for 9 years, with the latest figure at -$18.0 million in Q4 2025.

• Quarterly Cash from Financing Activities fell 377.41% year-over-year to -$18.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$85.1 million (down 2277.47% YoY) and the FY2025 annual result came in at -$50.7 million, down 404.24% from the prior year.
• Cash from Financing Activities advanced to -$18.0 million in Q4 2025 per BIOX's latest filing, from -$28.7 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $40.2 million in Q3 2022 and troughed at -$28.7 million in Q3 2025.
• A 5-year average of -$2.0 million and a median of $409238.0 in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 828.27% in 2024, then plunged 583.16% in 2025.
• Over 5 years, Cash from Financing Activities stood at $4.9 million in 2021, then slumped by 97.57% to $119779.0 in 2022, then soared by 483.32% to $698697.0 in 2023, then soared by 828.27% to $6.5 million in 2024, then sank by 377.41% to -$18.0 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$18.0 million, -$28.7 million, and -$25.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.